| ID | 1097 |
| Name of the vaccine | Td Adsorbed |
| Microbe | Bacteria |
| Disease name | Tetanus (Lock Jaw) |
| Name of bacteria | Clostridium tetani |
| Type of vaccine | Toxoid |
| Nucleic acid content | DNA |
| Age | 7 years and older |
| Description of the vaccine | Tetanus and diphtheria toxoids adsorbed. |
| Name of the manufacturer | Sanofi Pasteur Ltd |
| Name of the manufacturing country | Canada |
| Year of manufacture | 2012 |
| Clinical Phase status | Approved |
| Bacterial strain | An obligate anaerobic bacillus, which is gram positive. |
| Efficacy | NA |
| Vaccine formulation | Suspension for injection |
| Dosage | Primary immunisation - Three doses.
Booster- Single dose at 10 year interval. |
| Mechanism of action | Serum tetanus antitoxin level:
at least 0.01 IU/mL: Minimum protective level
at least 0.1 IU/mL : Protective
1.0 IU/mL: Long term protection
|
| Route of administration | Intramuscular |
| Indications | Immunization against tetanus and diphtheria. |
| Export | NA |
| Approval | NA |
| Adjuvant | Aluminium phosphate |
| Repurposing | For diphtheria also. |
| Side effects of vaccine | Pain, swelling, redness, fever, chills and sore joints. |
| Post vaccination | NA |
| Dose type | Combination (4 doses) |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NA |
| Reference | http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=771&keywords= |
| Other name | NA |
| Additional Links | https://pdf.hres.ca/dpd_pm/00020609.PDF
|